Blog

The 83(b) Election for Biotech Founders: Why You Have 30 Days to Save Thousands in Taxes

The 83(b) Election for Biotech Founders: Why Yo...

Discover how the 83(b) election can save thousands in taxes for Biotech founders. Learn the importance of the 30-day filing window in our comprehensive guide.

The 83(b) Election for Biotech Founders: Why Yo...

Discover how the 83(b) election can save thousands in taxes for Biotech founders. Learn the importance of the 30-day filing window in our comprehensive guide.

409A Valuations for Biotech Companies: Impact on Option Grants and Cap Table Planning

409A Valuations for Biotech Companies: Impact o...

Discover how 409A valuations influence option grants and cap table planning in biotech companies. Learn strategies to mitigate their impact and optimize your company's financial strategy.

409A Valuations for Biotech Companies: Impact o...

Discover how 409A valuations influence option grants and cap table planning in biotech companies. Learn strategies to mitigate their impact and optimize your company's financial strategy.

Pro Rata Rights and Participation Rights: How Investor Protections Affect Biotech Founder Dilution

Pro Rata Rights and Participation Rights: How I...

Learn how pro rata rights and participation rights, as investor protections, can impact biotech founder dilution. Discover negotiation strategies to balance interests.

Pro Rata Rights and Participation Rights: How I...

Learn how pro rata rights and participation rights, as investor protections, can impact biotech founder dilution. Discover negotiation strategies to balance interests.

Biotech Co-Founder Equity Splits: Vesting Structures and Dilution-Proof Agreements

Biotech Co-Founder Equity Splits: Vesting Struc...

Understand the nuances of biotech co-founder equity splits, vesting structures, and dilution-proof agreements. Learn how to balance these elements for a fair startup agreement.

Biotech Co-Founder Equity Splits: Vesting Struc...

Understand the nuances of biotech co-founder equity splits, vesting structures, and dilution-proof agreements. Learn how to balance these elements for a fair startup agreement.

Secondary Transaction Management for Biotech Startups: Updating Your Cap Table Without Triggering Rights

Secondary Transaction Management for Biotech St...

Explore how to manage secondary transactions for biotech startups effectively. Learn to update your cap table without triggering rights with our comprehensive guide.

Secondary Transaction Management for Biotech St...

Explore how to manage secondary transactions for biotech startups effectively. Learn to update your cap table without triggering rights with our comprehensive guide.

Bridge Rounds and Convertible Notes in Biotech: Modeling Future Dilution from SAFEs and Debt Conversion

Bridge Rounds and Convertible Notes in Biotech:...

Discover the intricate world of bridge rounds and convertible notes in biotech. Learn how modeling future dilution from SAFEs and debt conversion can impact your venture.

Bridge Rounds and Convertible Notes in Biotech:...

Discover the intricate world of bridge rounds and convertible notes in biotech. Learn how modeling future dilution from SAFEs and debt conversion can impact your venture.